You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 284 No. 11, September 20, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Relationship Between Caffeine Intake and Parkinson Disease

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The article by Dr Ross and colleagues1 was widely reported to show that coffee is an independent "protective factor" against the development of Parkinson disease (PD). Using a prospective longitudinal epidemiological database, the authors did, in fact, find an inverse association between higher caffeine intake and risk of developing PD. However, association does not prove causation. They did not consider another potential explanation of this association; namely, that incipient or preclinical PD causes decreased novelty-seeking behaviors.2-3 Several studies have shown inverse associations between tobacco, alcohol, and coffee intake and PD,1-3 and it is more plausible that these various substances (including other caffeinated beverages such as tea, cola, and chocolate) are underused by persons with incipient PD, rather than that each agent independently protects against PD.

Patients destined to develop clinical PD may have a presymptomatic period of 5 to 20 years, during which they may manifest early . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Parkinson's Disease and Tea: A Quantitative Review
Barranco Quintana et al.
J. Am. Coll. Nutr. 2009;28:1-6.
ABSTRACT | FULL TEXT  

Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels
Guerreiro et al.
Mol. Pharmacol. 2008;74:980-989.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.